Advanced Medical Solutions Group (LON:AMS) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next?

Shares of Advanced Medical Solutions Group plc (LON:AMS) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 213.35 and traded as high as GBX 219.25. Advanced Medical Solutions Group shares last traded at GBX 215.50, with a volume of 555,265 shares changing hands.

Analysts Set New Price Targets

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 300 price objective on shares of Advanced Medical Solutions Group in a report on Thursday, January 15th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Advanced Medical Solutions Group has an average rating of “Buy” and an average target price of GBX 273.67.

Advanced Medical Solutions Group Trading Down 0.5%

The firm has a market cap of £466.25 million, a P/E ratio of 51.68, a P/E/G ratio of 5.00 and a beta of 0.74. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. The firm has a fifty day moving average of GBX 216.79 and a 200-day moving average of GBX 213.35.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.